bims-mithem Biomed News
on Mitochondria in Hematopoiesis
Issue of 2026–06–21
two papers selected by
Tim van Tienhoven, Erasmus Medical Center



  1. Stem Cell Reports. 2026 Jun 18. pii: S2213-6711(26)00176-1. [Epub ahead of print] 102965
      Aging of the hematopoietic system has profound consequences for organismal health and longevity, attributed to the well-characterized functional aging of hematopoietic stem cells (HSCs). Here, we tested whether progenitor cells may demonstrate age resistance to enable hematopoietic homeostasis throughout life despite the functional decline of upstream HSCs. Strikingly, our results revealed unwavering reconstitution capacity by young and old progenitors, demonstrating that intermediate progenitors are functionally unaffected by aging and placing Flk2+ multipotent progenitors (MPPFs) as a potential source of age resilience. This unique finding was emphasized by unchanged transcriptomic, proliferation, and mitochondrial capacity of young and old MPPFs, revealing remarkable similarities upon aging. Considering that HSCs functionally decline with age, yet intermediate progenitors remain unperturbed and "age resilient", we posit that MPPFs may play an essential role in protecting downstream progenitors from inheriting age-related properties from HSCs. We propose three potential mechanisms for how MPPFs maintain hematopoietic integrity and homeostasis with age.
    Keywords:  age resilience; aging; aging homeostasis; hematopoietic progenitor cells; hematopoietic reconstitution; hematopoietic stem cells; longevity; multipotent progenitor cells; single-cell RNA sequencing; transcriptomics; transplantation
    DOI:  https://doi.org/10.1016/j.stemcr.2026.102965
  2. Aging Dis. 2026 Jun 05.
      Mitochondria function as the primary energy centers of cells, and the dynamic equilibrium between their fission and fusion is essential for preserving cellular functional integrity and metabolic homeostasis. As research in cell biology has advanced, an imbalance in mitochondrial dynamics is tightly and bidirectionally linked to cellular aging. It not only contributes to aging-related functional decline but is also exacerbated by the senescent state itself, creating a vicious cycle that impacts key biological processes. Recent studies have demonstrated that the disruption of mitochondrial fission and fusion during aging, through mechanisms such as impaired cellular energy metabolism, increased oxidative stress, compromised mitophagy, and the induction of senescence-associated secretory phenotypes, collectively accelerates the functional decline of cells and organs. Nonetheless, many questions remain regarding the specific regulatory network of mitochondrial dynamics and its variations across different stages of aging. The aim of this review is to systematically elucidate the fundamental role of imbalances in mitochondrial dynamics in the context of cellular aging, along with its underlying molecular mechanisms. This review summarizes various intervention strategies targeting this process, including targeted therapies, small molecule regulators, stem cell therapy, lifestyle modifications, and innovative mitochondrial transplantation technology, whereas these approaches are still in experimental or early-stage development, and their translational potential requires further validation. The ultimate objective is to offer novel theoretical insights and potential therapeutic approaches for mitigating aging and associated diseases.
    DOI:  https://doi.org/10.14336/AD.2026.0323